Recigar 1.5 mg Film-Coated Tablets

What Is Recigar and What Is It Used For?

Recigar 1.5 mg is a prescription-only film-coated tablet taken by mouth. As a prescription medicine, it is supplied to treat a specific medical condition determined by your doctor based on your individual diagnosis, risk profile and treatment goals. The exact licensed indications and approved use depend on the regulatory authority in your country and the most current Summary of Product Characteristics (SmPC) or prescribing information.

Recigar belongs to the broad category of orally administered prescription medicines that are formulated as film-coated tablets. The film coating around the tablet core serves several important purposes: it masks the taste and odour of the active ingredient, makes the tablet easier to swallow, protects the active substance from moisture and oxidation, and in some products allows for delayed or modified release of the drug into the body. A 1.5 mg strength suggests that the active ingredient is potent at relatively low doses, which is typical of medicines that bind selectively to specific biological targets such as receptors, enzymes or transporters.

Because prescription medicines are only authorised for use after extensive evaluation by national regulatory agencies – such as the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA), the UK Medicines and Healthcare products Regulatory Agency (MHRA), Health Canada and the Therapeutic Goods Administration (TGA) in Australia – the indications, dosing instructions and safety warnings for Recigar will be set out in the country-specific product label that accompanies your pack. This document, often called the Patient Information Leaflet (PIL) or Medication Guide, is the most reliable source of information about your specific product.

It is important to understand that the same brand name can sometimes refer to different formulations in different countries, and that the same active substance can be marketed under multiple brand names. If you have received Recigar from a pharmacy and the appearance of the tablets, the carton or the leaflet differs from a previous supply, ask your pharmacist to confirm that you have been given the correct medicine before taking the first dose. Do not assume that two products are identical simply because they share part of a name.

Whatever the specific reason your doctor has prescribed Recigar, the principles of safe use are universal: take it exactly as instructed, store it correctly, do not share it with anyone else, and seek prompt advice if your symptoms change or if you experience side effects. The remainder of this guide explains those principles in detail and shows you how to use Recigar as part of a wider plan of medical care.

What Should You Know Before Taking Recigar?

Before you take the first tablet of Recigar 1.5 mg, give your doctor a complete picture of your health: any chronic conditions, previous adverse drug reactions, current medications and supplements, alcohol or recreational drug use, pregnancy or planned pregnancy, and breastfeeding status. This information allows your prescriber to confirm that Recigar is suitable for you, choose the correct dose, and set up appropriate monitoring.

Contraindications

A contraindication is a specific situation in which a medicine should not be used because the risk of harm is too high. The most universal contraindication for any medication is a known hypersensitivity (allergy) to the active substance or to any of the excipients (inactive ingredients) listed in the patient information leaflet. If you have ever had a serious allergic reaction to a tablet that contained the same active ingredient as Recigar – including symptoms such as widespread rash, swelling of the face, lips or tongue, or difficulty breathing – you must not take Recigar.

Your doctor will check for additional contraindications based on the country-specific labelling for Recigar. These may include severe organ impairment (such as severe liver or kidney disease), specific concomitant medications, recent or planned surgical procedures, or particular cardiovascular conditions. Always answer your doctor’s questions about your past and present medical history fully and honestly – omitting information is one of the most common causes of avoidable medication harm.

Warnings and Precautions

Your doctor will tell you about the specific warnings that apply to Recigar based on its mechanism of action and known safety profile. Common categories of warnings for prescription tablets include precautions for elderly patients, patients with reduced kidney or liver function, patients taking medicines that share the same metabolic pathway, and patients with cardiovascular, neurological or psychiatric conditions. Read the patient information leaflet supplied with each pack – warning sections are sometimes updated as new evidence emerges from post-marketing surveillance.

Tell your doctor if you have any of the following before starting Recigar: a history of liver disease or hepatitis; a history of kidney disease or current dialysis treatment; any heart condition, including arrhythmias, heart failure or recent heart attack; high or low blood pressure that is poorly controlled; bleeding disorders or treatment with blood thinners; uncontrolled diabetes; epilepsy or other seizure disorders; depression, anxiety, bipolar disorder or other mental health conditions; recent or planned surgery; lactose intolerance or other dietary intolerances if your tablets contain lactose or other excipients you cannot tolerate.

If you are scheduled for a planned operation or invasive dental procedure, inform the surgical or dental team well in advance that you are taking Recigar. Some prescription medicines must be paused or replaced around the time of surgery to reduce bleeding, anaesthesia or wound-healing risks. Never stop a prescribed medicine yourself before a procedure – ask the team caring for you which medicines to continue and which to hold.

Pregnancy and Breastfeeding

Tell your doctor before starting Recigar if you are pregnant, think you may be pregnant, are planning a pregnancy or are breastfeeding. Many prescription medicines have been studied only in non-pregnant adults, and the developing fetus and breastfed infant may be more vulnerable to drug effects than the mother. Pregnancy advice for Recigar is set by the marketing authorisation in your country and reflects the available human and animal data; it may range from “not recommended at any stage” through “use only if benefits outweigh risks” to “safe for use during pregnancy with appropriate monitoring”.

If you are of child-bearing potential and are taking Recigar, ask your doctor whether reliable contraception is required during treatment and for any specified period after stopping. If you become pregnant while taking Recigar, do not stop the medication abruptly without medical advice – instead, contact your doctor as soon as possible to discuss the safest course of action. Where pregnancy registries exist for a particular medicine, you may be invited to enrol so that researchers can collect outcome data that benefits future patients.

For breastfeeding parents, the question is whether the active substance and any pharmacologically active metabolites pass into breast milk in clinically meaningful quantities, and whether the infant is likely to absorb them. Your doctor or pharmacist will weigh these considerations against the well-established benefits of breastfeeding and the importance of the medicine for your own health. In some cases, the medicine and breastfeeding can continue together; in others, an alternative medicine, temporary feeding interruption or expressed-and-discard strategy may be recommended.

Driving, Operating Machinery and Daily Activities

Some prescription tablets can cause drowsiness, dizziness, blurred vision or slowed reactions, particularly when treatment is first started or after a dose increase. Until you know how Recigar affects you, do not drive, operate heavy machinery or perform other safety-critical activities. If you experience persistent drowsiness, dizziness or coordination problems while taking Recigar, tell your doctor – the dose may need to be adjusted or the timing of doses changed.

Alcohol and Recreational Substances

Alcohol can interact with many prescription medicines, either by intensifying side effects (such as drowsiness, dizziness, low blood pressure or stomach irritation) or by altering how the medicine is broken down by the liver. Ask your prescriber whether moderate alcohol consumption is safe with Recigar, and if so, what limits to observe. Recreational substances, including cannabis, can also interact with prescription drugs – share this information with your healthcare team in confidence so they can advise you safely.

How Does Recigar Interact with Other Drugs?

Drug interactions can occur with any prescription medicine. Before starting Recigar, give your doctor and pharmacist a complete list of every medication you currently take – prescription, non-prescription, herbal, vitamin and supplement – and update this list whenever it changes. The categories below describe the most common interaction patterns to be alert for; the precise interactions that apply to Recigar will be listed in the patient information leaflet packaged with your medicine.

Drug interactions are usually classified by mechanism. Pharmacokinetic interactions occur when one drug changes how another drug is absorbed, distributed, metabolised or excreted – for example, by inducing or inhibiting the cytochrome P450 enzymes in the liver. Pharmacodynamic interactions occur when two drugs act on the same body system to produce additive, synergistic or opposing effects – for example, two medicines that both lower blood pressure may cause excessive hypotension when taken together. Both types of interaction can be clinically significant, and both can sometimes be managed safely with dose adjustment, separation of doses or additional monitoring.

Major Interaction Categories

The categories below cover the medication classes that most commonly require attention when starting a new prescription tablet. Tell your healthcare team if you take any of these, and do not start any new medicine in these categories without checking first.

Lower-Risk but Still Important Interactions

Not every interaction requires the medicine to be stopped. Many can be managed simply by separating doses, taking the tablet with or without food as instructed, or by performing a single additional blood test. For example, antacids and iron or calcium supplements can sometimes reduce the absorption of oral tablets and may need to be taken several hours apart. High-fibre meals or a sudden change in dietary habits can occasionally affect drug absorption too. Your pharmacist can give you specific advice on how and when to take Recigar in relation to your other medicines and meals.

Food and Drink

Some film-coated tablets must be taken with food to improve absorption or reduce stomach upset; others must be taken on an empty stomach because food slows or reduces absorption. The patient information leaflet for Recigar will state whether your dose should be taken before, during or after meals. Pay particular attention to any specific foods or drinks listed as needing to be avoided – the most common example is grapefruit and grapefruit juice, which can substantially increase the blood levels of certain oral medicines.

What Is the Correct Dosage of Recigar?

The dose of Recigar 1.5 mg that is right for you is the dose your doctor has prescribed. Take it exactly as instructed: at the prescribed times, by the prescribed route (orally, with the recommended amount of water), and for the prescribed duration. Never adjust the dose, skip days or stop treatment early without medical advice – even if you feel better. The general dosing principles below apply to most prescription oral tablets.

Prescribers individualise the dose of any oral tablet based on a number of factors including age, body weight, kidney and liver function, severity of the condition being treated, response to previous treatments, concomitant medications and overall health. The 1.5 mg strength of Recigar may be used as the standard adult dose, as one component of a step-up titration, or as a maintenance dose after a higher induction dose. Your prescriber will explain which schedule applies to you and write the instructions on the dispensing label of your pack.

Adults – General Dosing Principles

Children and Adolescents

Many prescription medicines have not been adequately studied in children and adolescents under 18 years of age, and use in this age group is therefore restricted, off-label or specifically contraindicated. If Recigar has been prescribed for a child or adolescent, the prescriber will have made an individualised judgement based on the available paediatric evidence and on the child’s clinical situation. Parents and carers should follow the prescribed schedule precisely, supervise dosing for younger children and report any concerning symptoms promptly.

Older Adults

Older adults are often more sensitive to the effects of medicines because of age-related changes in kidney and liver function, alterations in body composition, and the higher likelihood of taking multiple medicines at the same time (polypharmacy). For this reason, prescribers may start treatment in older adults at a lower dose, increase the dose more gradually and monitor more closely. If you are over 65 and taking Recigar, ask your doctor whether any specific dose adjustment, monitoring schedule or fall-prevention strategy is recommended for you.

Patients with Kidney or Liver Impairment

The kidneys and liver are the main organs responsible for removing medicines from the body. When either is impaired, blood levels of a drug can build up to higher than expected, increasing the risk of side effects. The patient information leaflet for Recigar will state whether dose adjustment is recommended for patients with mild, moderate or severe kidney or liver impairment, and whether the medicine is contraindicated when organ function falls below a certain threshold. Your prescriber will arrange any blood tests needed to assess organ function before and during treatment.

Missed Dose

If you forget a dose of Recigar, take it as soon as you remember – unless it is almost time for the next scheduled dose. In that case, skip the missed dose and continue with your regular schedule. Never take a double dose to make up for a forgotten one; doubling the dose can sharply increase the risk of side effects. If you regularly miss doses, ask your pharmacist about practical aids such as weekly pillboxes, smartphone reminders or once-daily simpler regimens.

Overdose

If you (or someone else) accidentally takes more Recigar than prescribed, contact your local poisons control centre, your doctor or the nearest hospital emergency department immediately. Take the medicine pack and the patient information leaflet with you so the medical team knows exactly what was taken. Even if no symptoms have appeared, do not wait to see what happens – some overdose effects can be delayed by hours, and early supportive care often produces the best outcome.

What Are the Side Effects of Recigar?

Like all medicines, Recigar 1.5 mg may cause side effects, although not everybody will experience them. The side effect profile is set out in the patient information leaflet using the standard frequency categories shown below: very common, common, uncommon, rare and very rare. Most prescription tablets cause side effects in some patients that are mild, self-limiting and resolve as the body adjusts; serious side effects are uncommon but require prompt medical review.

Side effects are usually grouped by frequency rather than severity. A common side effect such as mild nausea may not be serious, while an uncommon side effect such as severe allergic reaction may be life-threatening. The categories below show the typical pattern of how prescription tablets are described in regulatory documents; the precise list of side effects that have been reported with Recigar will be in your patient information leaflet, and you should read it carefully before starting treatment.

The lists above are illustrative, not exhaustive. The complete and country-specific list of adverse reactions for Recigar is published in the official patient information leaflet that comes with your medicine and in the Summary of Product Characteristics on your national medicines regulator’s website. New side effects may be added over time as data accumulates from real-world use, which is one of the reasons why patients and healthcare professionals are encouraged to report suspected adverse reactions to the relevant pharmacovigilance authority.

How Should You Store Recigar?

Store Recigar 1.5 mg tablets in their original packaging, at room temperature, in a dry place out of direct sunlight, and out of the sight and reach of children. Do not use the tablets after the expiry date printed on the carton. Return any unused or expired medicines to your pharmacy for safe disposal – never flush them down the toilet or throw them in household waste.

Proper storage of Recigar is essential to preserve the chemical stability and clinical effectiveness of the active ingredient throughout the labelled shelf life. Most film-coated tablets are stable at normal room temperature (typically below 25-30 °C) when kept in their original packaging, which is designed to protect the tablets from moisture, oxygen and light. Specific storage conditions for your batch of Recigar will be printed on the carton and in the patient information leaflet – always follow these instructions in preference to general advice.

• Temperature: Store at the temperature specified on the carton, typically below 25-30 °C. Do not store in the refrigerator unless the leaflet specifically instructs you to do so.
• Humidity and light: Keep the tablets in the original blister or container; the packaging is designed to protect from moisture and light. Do not transfer tablets to a different container without first checking with your pharmacist.
• Out of reach of children: Even one tablet of an adult medicine can be harmful to a small child. Store medicines in a locked cupboard or in a secure box well above the reach of curious hands.
• Travel: When travelling, keep Recigar in your hand luggage rather than checked baggage so that temperature extremes and loss of luggage do not interrupt your treatment. Carry your prescription and a copy of the patient information leaflet to satisfy customs and security checks.
• Bathroom storage to be avoided: Bathrooms are usually warm and humid, which can degrade tablets faster than cooler, dry rooms. A bedroom drawer or a kitchen cupboard away from the cooker is usually a better choice.
• Expiry date: Check the expiry date (often shown as “EXP”) on the carton and blister strip. The expiry date refers to the last day of the month shown. Do not use Recigar after this date even if the tablets look unchanged – the active ingredient may have degraded.
• Disposal: Do not throw unused medicines into household rubbish or flush them down the toilet, as this can pollute water supplies and may pose a risk to wildlife. Return them to a pharmacy or community medicine take-back scheme.

If you discover that tablets have been stored at extreme temperatures (for example, in a hot car for several hours, or accidentally frozen), consult your pharmacist before taking them. Visible changes such as discoloration, cracking, broken film coating or unusual smell are all reasons to contact the pharmacy for a replacement supply rather than risk taking compromised medicine.

What Does Recigar Contain?

Each Recigar 1.5 mg film-coated tablet contains 1.5 mg of the active ingredient as listed on the carton, together with a number of inactive ingredients (excipients) used to produce a stable, palatable and easily swallowed tablet. The exact list of excipients is printed in the patient information leaflet packaged with your medicine and may differ slightly between manufacturers and between countries.

Active Ingredient

The active substance in Recigar is identified on the carton and patient information leaflet as recigar at a strength of 1.5 mg per film-coated tablet. The active ingredient is the chemical entity responsible for the medicine’s therapeutic effect; the strength tells you how much of that ingredient is delivered with each tablet. Always confirm the active ingredient name on the carton matches the prescription label before taking the first dose, especially if you have switched between brands or generic versions of the same medicine.

Inactive Ingredients (Excipients)

Film-coated tablets typically contain three groups of excipients: core excipients (such as lactose, microcrystalline cellulose, mannitol or starch as fillers; croscarmellose sodium or sodium starch glycolate as disintegrants; magnesium stearate as a lubricant; and colloidal silica as a glidant), film-coating excipients (such as hypromellose or polyvinyl alcohol as the coating polymer, titanium dioxide for opacity, talc, polyethylene glycol or polysorbate as a plasticiser/wetting agent, and various iron oxides or aluminium lakes for colour), and printing inks when the tablet is debossed or printed with markings.

If you have known allergies or intolerances – for example to lactose, gluten, sulphites or specific colouring agents – check the excipient list in your Recigar patient information leaflet carefully before taking the first dose. People with rare hereditary conditions such as galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take medicines that contain lactose. Vegan and vegetarian patients may also wish to confirm that none of the excipients (for example, gelatine in some coatings) are of animal origin.

Pack Size and Appearance

Recigar 1.5 mg film-coated tablets are supplied in standard pharmaceutical packaging – typically aluminium-aluminium or aluminium-PVC blister strips inside a printed cardboard carton, accompanied by a patient information leaflet. Pack sizes vary by country and may not all be marketed locally. The tablets’ physical appearance (size, shape, colour and any printed code) is described in the patient information leaflet; if your tablets look different from the description or from a previous supply, ask your pharmacist to verify them before you take a dose.